1210 related articles for article (PubMed ID: 33137809)
1. Age-specific mortality and immunity patterns of SARS-CoV-2.
O'Driscoll M; Ribeiro Dos Santos G; Wang L; Cummings DAT; Azman AS; Paireau J; Fontanet A; Cauchemez S; Salje H
Nature; 2021 Feb; 590(7844):140-145. PubMed ID: 33137809
[TBL] [Abstract][Full Text] [Related]
2. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
4. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.
Liu JQ; Xu JW; Sun CY; Wang JN; Wang XT; Chen X; Gao SL
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12575-12578. PubMed ID: 33336777
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.
Undurraga EA; Chowell G; Mizumoto K
Infect Dis Poverty; 2021 Feb; 10(1):11. PubMed ID: 33531085
[TBL] [Abstract][Full Text] [Related]
9. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
Pastor-Barriuso R; Pérez-Gómez B; Hernán MA; Pérez-Olmeda M; Yotti R; Oteo-Iglesias J; Sanmartín JL; León-Gómez I; Fernández-García A; Fernández-Navarro P; Cruz I; Martín M; Delgado-Sanz C; Fernández de Larrea N; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Larrauri A; Pollán M;
BMJ; 2020 Nov; 371():m4509. PubMed ID: 33246972
[TBL] [Abstract][Full Text] [Related]
10. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut.
Mahajan S; Caraballo C; Li SX; Dong Y; Chen L; Huston SK; Srinivasan R; Redlich CA; Ko AI; Faust JS; Forman HP; Krumholz HM
Am J Med; 2021 Jun; 134(6):812-816.e2. PubMed ID: 33617808
[TBL] [Abstract][Full Text] [Related]
12. A particle swarm optimization approach for predicting the number of COVID-19 deaths.
Haouari M; Mhiri M
Sci Rep; 2021 Aug; 11(1):16587. PubMed ID: 34400735
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
[TBL] [Abstract][Full Text] [Related]
15. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
16. Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic.
Modi C; Böhm V; Ferraro S; Stein G; Seljak U
Nat Commun; 2021 May; 12(1):2729. PubMed ID: 33980836
[TBL] [Abstract][Full Text] [Related]
17. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.
Wagner R; Peterhoff D; Beileke S; Günther F; Berr M; Einhauser S; Schütz A; Niller HH; Steininger P; Knöll A; Tenbusch M; Maier C; Korn K; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200766
[TBL] [Abstract][Full Text] [Related]
18. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
Yang HS; Racine-Brzostek SE; Karbaschi M; Yee J; Dillard A; Steel PAD; Lee WT; McDonough KA; Qiu Y; Ketas TJ; Francomano E; Klasse PJ; Hatem L; Westblade L; Wu H; Chen H; Zuk R; Tan H; Girardin RC; Dupuis AP; Payne AF; Moore JP; Cushing MM; Chadburn A; Zhao Z
Biosens Bioelectron; 2021 Apr; 178():113008. PubMed ID: 33515984
[TBL] [Abstract][Full Text] [Related]
19. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
20. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
